Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1

NCT03518060 · clinicaltrials.gov ↗

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: JULUCA

Sponsor

ViiV Healthcare

Collaborators

[object Object]